Studies have found that DNLA can reduce the loss of neurons and Nissl bodies in the hippocampus and cortex, improve the expansion and swelling of the ER in hippocampal neurons, and reduce the hyperphosphorylation of tau protein, thereby improving learning and memory impairment (Liu et al., 2020). The gene discussed is MAPT; the disease is memory impairment.